Comparative Effects of Metformin and GLP-1 Agonists on Polyendocrine Metabolic Ovary Syndrome and Gallbladder Disease
Polyendocrine metabolic ovarian syndrome (PMOS) is a common endocrine disorder affecting 5% to 15% of reproductive-aged individuals and is frequently accompanied by hyperinsulinemia and obesity. These metabolic disturbances contribute to gallbladder dysmotility and increased cholesterol synthesis, elevating the ris...